Topics / Ophthalmology

Weekly issue

Ophthalmology Papers of the Week

The top Ophthalmology papers of the week: the 20 most important new papers of the past week, ranked by potential impact. A new issue comes out every Monday, covering the previous Monday-to-Sunday week.

Nov 9 - 15, 2026 · Updated

Prefer new papers every day? It's free.Daily Ophthalmology Papers →
  1. 1
  2. 2
    Development and Validation of The Glaucoma Risk Stratification Questionnaire for Community Screening

    We developed and validated the Glaucoma Risk Stratification Questionnaire (GRSQ), a questionnaire-based instrument for identifying individuals at risk of glaucoma in Chinese communities. Methods This hospital-based cross-sectional study, constituting the instrument development and validation phase of a community screening program, was conducted at West China Hospital, Sichuan University, from December 2025 to August 2026.

  3. 3
    TMT-based Quantitative Proteomic Analysis of Vitreous Humor in Proliferative Diabetic Retinopathy

    This study used tandem mass tag (TMT) combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify DEPs in vitreous samples from PDR patients and MH/EMM control patients.

  4. 4
    Effect of Electronic Behavioral Nudges on Low-Value Preoperative Testing

    Objective To measure whether electronic health record (EHR)–embedded, behavioral science–informed nudges reduce preoperative testing. Design, Setting, and Participants This pragmatic randomized clinical trial was conducted at a large academic health system (UCLA Health) in Los Angeles, California.

  5. 5
    Angiotensin II Type 1 Receptor (AT1R) Drives Human Tenon's Capsule Fibroblast Activation and Myofibroblast Transformation Via The RhoA/ROCK Signaling Pathway

    This study investigated the expression of AT1R in human clinical scar specimens, the downstream involvement of the RhoA/ROCK pathway, and the independent anti-fibrotic effects of receptor blockade.

Get papers like these the day they come out, not a week later.

Follow this category
  1. 6
    Detection of Abnormalities in The RPE in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Chorioretinopathy Using Optical Coherence Tomography-Derived Optical Attenuation Coefficients

    To detect abnormalities in the RPE in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) chorioretinopathy, a novel method using optical attenuation coefficients (OACs) was used to enhance the contrast between regions with high and low attenuation.

  2. 7
  3. 8
    Cell-cycle Regulatory Responses in Retinal Degeneration: From Post-mitotic Homeostasis to Cell-state Transitions and Fate Decisions

    In this review, we examine cell-cycle perturbations across inherited retinal diseases (IRDs), age-related macular degeneration (AMD), diabetic retinopathy (DR), retinal gliosis and inflammation, and retinal organoid models.

  4. 9
  5. 10
    Gut-hormone Receptor Systems in The Eye: Pharmacological, Local and Putative Endocrine Signalling

    This review critically examines gut-hormone-related receptor systems in the eye across three biologically distinct evidence streams: endogenous circulating gut peptides, pharmacological receptor agonism, and locally synthesised ocular peptides.

  6. 11
  7. 12
    Artificial Intelligence for Anti-VEGF Management in Neovascular Age-related Macular Degeneration: from Predictive Models Toward Clinical Decision Agents

    However, most published studies remain retrospective, single-center, and prediction-focused, with limited external validation and little direct evidence for clinically deployable closed-loop decision systems. In this narrative review, we synthesize the literature across four linked domains: image interpretation, biomarker quantification, prediction of treatment-related outcomes, and agent-enabling technologies such as home monitoring and language-model-assisted decision support.

  8. 13
    Directionally Aligned Nanofibrous Polycaprolactone/gelatin Scaffolds As Durable Scleral Implants for Long‐term Ocular Reconstruction

    In this study, we developed electrospun polycaprolactone/gelatin (PCL/GE) nanofibrous scaffolds with controlled fiber orientation for long‐term scleral reconstruction.

  9. 14
  10. 15
    Prognostic Implications of Longitudinal ß-zone Peripapillary Atrophy Enlargement in Myopic Choroidal Neovascularization

    To investigate whether longitudinal change of ß-zone peripapillary atrophy (ß-PPA) is associated with long-term outcomes in myopic choroidal neovascularization (mCNV), and to explore its relationship with longitudinal choroidal thickness change. This retrospective longitudinal cohort study included 53 eyes with treatment-naïve subfoveal mCNV that underwent bevacizumab monotherapy and were followed for more than five years.

  11. 16
    Activity and Safety of First-line Pumitamig Plus Nab-paclitaxel in Triple-negative Breast Cancer: A Single-arm, Phase 1b/2 Trial

    We aimed to evaluate the safety and activity of pumitamig plus nab-paclitaxel as first-line treatment in patients with advanced or metastatic triple-negative breast cancer.

  12. 17
    Statin Use and Age-related Macular Degeneration: A Systematic Review and Meta-Analysis of Disease Outcomes

    This systematic review and meta-analysis evaluated the association between statin use and the prevalence, incidence, and progression of age-related macular degeneration (AMD).

  13. 18
    Genome-Wide Association Study Meta-Analysis of Central Serous Chorioretinopathy

    To elucidate the genetic architecture of CSC and map susceptibility loci to specific ocular cell types and molecular pathways. This genetic association study was a genome-wide association study (GWAS) meta-analysis aggregating data from 5 large biobank cohorts and included 2584 patients with CSC and 1 044 455 control participants of European ancestry.

  14. 19
    Early Macular Dryness After Four Loading Injections of Faricimab Was Associated with Reduced Two-year Treatment Burden in Treatment-naïve Neovascular Age-related Macular Degeneration

    To investigate the association of complete macular dryness after four loading injections of faricimab with treatment burden and dosing intervals over two years in treatment-naïve neovascular age-related macular degeneration (nAMD). This retrospective consecutive case series included treatment-naïve nAMD eyes treated with four monthly loading intravitreal injections of faricimab followed by a treat-and-extend (TAE) regimen in which treatment intervals were adjusted in 2-week increments according to disease activity.

  15. 20
    An Update on Pharmacotherapies and Emerging Therapeutic Approaches for Geographic Atrophy

    Based on searches of PubMed, trial registries, regulatory documents, and conference proceedings through September 2026, this review examines real-world experience with approved complement inhibitors; next-generation complement approaches, including C1q inhibition, systemic C5 and C3 suppression, and complement-directed gene therapies; and non-complement strategies targeting inflammation, mitochondrial dysfunction, apoptosis, the visual cycle, and iron homeostasis, with photobiomodulation and cell-based therapies as non-pharmacologic comparators.